Clinical Trial Update: Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Rhenium-188-HEDP to Radium-223-chloride in advanced prostate cancer with bone metastases; results not yet available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostate Cancer to Bone

Drugs mentioned

• Radium-223-chloride
• Rhenium-188-HEDP

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Prostate Cancer Metastatic to Bone | Phase 3 | Status: UNKNOWN